Selegiline is a selective monoamine oxidase B (MAO-B) inhibitor used to treat Parkinson’s disease and major depressive disorder. It is administered orally or transdermally and works by increasing dopaminergic activity in the brain. The term refers to the drug, not a common noun, and its pronunciation is often the main hurdle for non-English speakers in clinical settings, research papers, and patient education materials.
Full pronunciation guide
